Chi Michael, Chief Marketing Officer of Hims & Hers Health (HIMS), has demonstrated a clear selling bias in recent insider transactions, with $17.2 million in total sales outweighing $317,601 in buys across 60 reported trades. All activity has been concentrated in HIMS stock, with recent disposals accelerating in size. The most notable transactions include a $2.4 million sale on March 17, 2026, following two larger dispositions on March 13, 2026—a $971,331 sale and a $4.9 million transaction coded as a gift or transfer. This follows earlier sales of $504,763 on December 17, 2025, and $1.45 million on December 15, 2025, with smaller dispositions in late 2025 ranging from $14,000 to $118,692. The pattern shows no recent purchases, with all five most recent transactions being sales. The filings include multiple $0-value transactions likely representing option exercises or equity awards, but the monetization of holdings through open-market sales dominates the activity. The scale of selling—particularly the multi-million-dollar transactions in early 2026—suggests ongoing reduction of HIMS equity exposure despite Michael’s continued executive role.
AI-assisted summary